Seroquel Lawsuits
Seroquel is an oral medication that was cleared by the FDA in 1997. Seroquel is
manufactured by Zeneca Pharmaceuticals and is a member of a new chemical
class called dibenzothiazepine derivatives. Like other new "atypical"
antipsychotics, Seroquel has a reduced risk of side effects related to
loss of motor control, a major problem with older "typical" antipsychotics.
Extensive clinical trials show that Seroquel is effective in the treatment
of all manner of symptoms of schizophrenia, from delusions to apathy.
Seroquel affects a range of neurotransmitter receptors, including serotonin
receptors. Users of Seroquel have found the drug to be as effective as
traditional antipsychotic medications, including Thorazine (chlorpromazine)
and Haldol (haloperidol).
Seroquel manufacturers AstraZeneca have been requested by US regulators to
include warnings about the risk of elevated blood sugar and diabetes. The
Japanese Seroquel label includes a prominent warning, specifically stating
that there is a link between diabetes and the use of Seroquel. The United
States label, however, does not reflect this known problem, meaning that
Seroquel users and their physicians may be unaware of the need to monitor
for signs of diabetes. Seroquel patients who believe they have
suffered ill-effects from the use of the medication should contact an
attorney who is familiar with
Seroquel.
|